These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2946262)

  • 1. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
    Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
    Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
    Peeters M; Van Dyck E; Piot P
    Antimicrob Agents Chemother; 1984 Oct; 26(4):608-9. PubMed ID: 6240224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
    Sturm AW
    J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.
    Wall RA; Mabey DC; Bello CS; Felmingham D
    J Antimicrob Chemother; 1985 Aug; 16(2):165-8. PubMed ID: 3877717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
    Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
    J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
    Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.
    Hafiz S; Jones BM; Kinghorn GR; Duerden BI
    Genitourin Med; 1986 Aug; 62(4):251-2. PubMed ID: 2942458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.
    Taylor DN; Echeverria P; Hanchalay S; Pitarangsi C; Slootmans L; Piot P
    J Clin Microbiol; 1985 Mar; 21(3):442-4. PubMed ID: 3872313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.
    Jorgensen JH; Redding JS; Howell AW
    Antimicrob Agents Chemother; 1986 May; 29(5):921-2. PubMed ID: 3488019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
    Feltham S; Ronald AR; Albritton WL
    J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
    [No Abstract]   [Full Text] [Related]  

  • 11. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
    Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
    Goossens H; De Mol P; Coignau H; Levy J; Grados O; Ghysels G; Innocent H; Butzler JP
    Antimicrob Agents Chemother; 1985 Mar; 27(3):388-92. PubMed ID: 3158276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
    Abeck D; Johnson AP; Dangor Y; Ballard RC
    J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Haemophilus ducreyi.
    Hammond GW; Lian CJ; Wilt JC; Ronald AR
    Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
    Aldridge KE; Cammarata C; Martin DH
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products.
    Slootmans L; Vanden Berghe DA; Van Dyck E; Piot P
    Antimicrob Agents Chemother; 1983 Oct; 24(4):564-7. PubMed ID: 6606394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
    Ismaeel NA
    Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Ureaplasma urealyticum to ten chemotherapeutic agents.
    Sobetzko R; Hartmann AA; Elsner P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Aug; 269(2):245-50. PubMed ID: 2973712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
    Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.